A PHYSICAL FORM OF N-[4-[5-(CYCLOPENTYLOXYCARBONY)AMINO-1-METHYLINDOL-3YL-METHY1]-3-METHOXYBENZOY1]-2-METHLBENZENESULPHONAMIDE, PROCESSES FOR ITS PREPARATION AND COMPOSITIONS CONTAINING IT

The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxy- carbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methyl- benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and ano...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TIMKO, ROBERT J, HOLOHAN, JAMES J, CLEMENTS, ARLENE, BRADWAY, RANDY J, EDWARDS, IEUAN J
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxy- carbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxybenzoyl]-2-methyl- benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[S-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]- -3-methoxybenzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.